Sarcoma in the Young Adult Population: An International View

Seminars in Oncology

Volumn 36, Issue 3, 2009, Pages 227-236

  Soliman, Hatem ^a   Ferrari, Andrea ^b   Thomas, David ^c  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; ANTINEOPLASTIC AGENT; BENDAMUSTINE; BEVACIZUMAB; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DASATINIB; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE; IMATINIB; IRINOTECAN; METHOTREXATE; NILOTINIB; PACLITAXEL; SORAFENIB; SUNITINIB; TRABECTEDIN; VINBLASTINE; VINCRISTINE;

AGE DISTRIBUTION; AMENORRHEA; ARTICLE; BEDTIME DOSAGE; CANCER COMBINATION CHEMOTHERAPY; CHONDROSARCOMA; DERMATOFIBROSARCOMA PROTUBERANS; DRUG MEGADOSE; EWING SARCOMA; FIBROSARCOMA; GASTROINTESTINAL STROMAL TUMOR; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LEIOMYOSARCOMA; LIPOSARCOMA; MALIGNANT FIBROUS HISTIOCYTOMA; MULTIPLE CYCLE TREATMENT; NERVE SHEATH TUMOR; OCCUPATIONAL EXPOSURE; OSTEOSARCOMA; PRIORITY JOURNAL; RADIATION EXPOSURE; RHABDOMYOSARCOMA; RISK FACTOR; SARCOMA; SOFT TISSUE SARCOMA; SYNDROME; SYNOVIAL SARCOMA; TREATMENT INDICATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADULT; AGE FACTORS; BONE NEOPLASMS; HUMANS; OSTEOSARCOMA; SARCOMA; SOFT TISSUE NEOPLASMS;

EID: 65549120007     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2009.03.006     Document Type: Article

References (53)

1. Bleyer A. Young adult oncology: the patients and their survival challenges. CA Cancer J Clin 57 (2007) 242-255
2. Bleyer A., Barr R., Hayes-Lattin B., Thomas D., Ellis C., and Anderson B. The distinctive biology of cancer in adolescents and young adults. Nat Rev 8 (2008) 288-298
3. Bleyer A., Budd T., and Montello M. Adolescents and young adults with cancer: the scope of the problem and criticality of clinical trials. Cancer 107 Suppl (2006) 1645-1655
4. Bleyer A., Montello M., Budd T., and Saxman S. National survival trends of young adults with sarcoma: lack of progress is associated with lack of clinical trial participation. Cancer 103 9 (2005) 1891-1897
5. Curado M.P., Edwards B., Shin H.R., Storm H., Ferlay J., and Heanue M. Cancer incidence in five continents vol. IX (2007), IARC Scientific Publications, Lyon
6. Henderson T.O., Whitton J., Stovall M., Mertens A.C., Mitby P., Friedman D., et al. Secondary sarcomas in childhood cancer survivors: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 99 (2007) 300-308
7. Ji J., and Hemminki K. Incidence of multiple primary malignancies among patients with bone cancers in Sweden. J Cancer Res Clin Oncol 132 (2006) 529-535
8. Hoppin J.A., Tolbert P.E., Herrick R.F., Freedman D.S., Ragsdale B.D., Horvat K.R., et al. Occupational chlorophenol exposure and soft tissue sarcoma risk among men aged 30-60 years. Am J Epidemiol 148 (1998) 693-703
9. Hoppin J.A., Tolbert P.E., Flanders W.D., Zhang R.H., Daniels D.S., Ragsdale B.D., et al. Occupational risk factors for sarcoma subtypes. Epidemiology 10 (1999) 300-306 Cambridge, Mass
10. Zambon P., Ricci P., Bovo E., Casula A., Gattolin M., Fiore A.R., et al. Sarcoma risk and dioxin emissions from incinerators and industrial plants: a population-based case-control study (Italy). Environ Health 6 (2007) 19
11. Gennaro V., Ceppi M., Crosignani P., and Montanaro F. Reanalysis of updated mortality among vinyl and polyvinyl chloride workers: Confirmation of historical evidence and new findings. BMC Public Health 8 (2008) 21
12. Pyakurel P., Pak F., Mwakigonja A.R., Kaaya E., and Biberfeld P. KSHV/HHV-8 and HIV infection in Kaposi's sarcoma development. Infect Agent Cancer 2 (2007) 4
13. Dupont C., Vasseur E., Beauchet A., Aegerter P., Berthe H., de Truchis P., et al. Long-term efficacy on Kaposi's sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients. CISIH 92. Centre d'information et de soins de l'immunodeficience humaine. AIDS 14 (2000) 987-993
14. Jones R.L., Fisher C., Al-Muderis O., and Judson I.R. Differential sensitivity of liposarcoma subtypes to chemotherapy. Eur J Cancer 41 (2005) 2853-2860
15. Pervaiz N., Colterjohn N., Farrokhyar F., Tozer R., Figueredo A., and Ghert M. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer 113 (2008) 573-581
16. Frustaci S., Gherlinzoni F., De Paoli A., Bonetti M., Azzarelli A., Comandone A., et al. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. J Clin Oncol 19 (2001) 1238-1247
17. Ferrari A., and Casanova M. New concepts for the treatment of pediatric nonrhabdomyosarcoma soft tissue sarcomas. Expert Rev Anticancer Ther 5 (2005) 307-318
18. Verma S., Younus J., Stys-Norman D., Haynes A.E., and Blackstein M. Meta-analysis of ifosfamide-based combination chemotherapy in advanced soft tissue sarcoma. Cancer Treat Rev 34 (2008) 339-347
19. Schwab J.H., Boland P., Guo T., Brennan M.F., Singer S., Healey J.H., et al. Skeletal metastases in myxoid liposarcoma: an unusual pattern of distant spread. Ann Surg Oncol 14 (2007) 1507-1514
20. Grosso F., Jones R.L., Demetri G.D., Judson I.R., Blay J.Y., Le Cesne A., et al. Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study. Lancet Oncol 8 (2007) 595-602
21. Maki R.G. Gemcitabine and docetaxel in metastatic sarcoma: past, present, and future. Oncologist 12 (2007) 999-1006
22. Hensley M.L., Maki R., Venkatraman E., Geller G., Lovegren M., Aghajanian C., et al. Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. J Clin Oncol 20 (2002) 2824-2831
23. Hartmann J.T., Mayer F., Schleicher J., Horger M., Huober J., Meisinger I., et al. Bendamustine hydrochloride in patients with refractory soft tissue sarcoma: a noncomparative multicenter phase 2 study of the German sarcoma group (AIO-001). Cancer 110 (2007) 861-866
24. Fanburg-Smith J.C., and Miettinen M. Angiomatoid "malignant" fibrous histiocytoma: a clinicopathologic study of 158 cases and further exploration of the myoid phenotype. Hum Pathol 30 (1999) 1336-1343
25. Remstein E.D., Arndt C.A., and Nascimento A.G. Plexiform fibrohistiocytic tumor: clinicopathologic analysis of 22 cases. Am J Surg Pathol 23 (1999) 662-670
26. Adam L.R., Davison E.V., Malcolm A.J., Pearson A.D., and Craft A.W. Cytogenetic analysis of a congenital fibrosarcoma. Cancer Genet Cytogenet 52 (1991) 37-41
27. Albritton K., Ferrari A., and Casanova M. Soft Tissue Sarcomas. In: Bleyer A., and Duncan R. (Eds). Cancer in Adolescents and Young Adults (2007), Springer, Berlin 185-199
28. Ferrari A., Dileo P., Casanova M., Bertulli R., Meazza C., Gandola L., et al. Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution. Cancer 98 (2003) 571-580
29. Crist W., Gehan E.A., Ragab A.H., Dickman P.S., Donaldson S.S., Fryer C., et al. The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 13 (1995) 610-630
30. El-Badry O.M., Minniti C., Kohn E.C., Houghton P.J., Daughaday W.H., and Helman L.J. Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumors. Cell Growth Differ 1 (1990) 325-331
31. Ferrari A., Gronchi A., Casanova M., Meazza C., Gandola L., Collini P., et al. Synovial sarcoma: a retrospective analysis of 271 patients of all ages treated at a single institution. Cancer 101 (2004) 627-634
32. Lee S.Y., Obata Y., Yoshida M., Stockert E., Williamson B., Jungbluth A.A., et al. Immunomic analysis of human sarcoma. Proc Natl Acad Sci U S A 100 (2003) 2651-2656
33. Ferner R.E., and Gutmann D.H. International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis. Cancer Res 62 (2002) 1573-1577
34. Maki R.G., Awan R.A., Dixon R.H., Jhanwar S., and Antonescu C.R. Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans. Int J Cancer 100 (2002) 623-626
35. Cattelan A.M., Calabro M.L., De Rossi A., Aversa S.M., Barbierato M., Trevenzoli M., et al. Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy. Int J Oncol 27 (2005) 779-785
36. Gill P.S., Tulpule A., Espina B.M., Cabriales S., Bresnahan J., Ilaw M., et al. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma. J Clin Oncol 17 (1999) 1876-1883
37. Gill P.S., Wernz J., Scadden D.T., Cohen P., Mukwaya G.M., von Roenn J.H., Jacobs M., et al. Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma. J Clin Oncol 14 (1996) 2353-2364
38. Miettinen M., Lasota J., and Sobin L.H. Gastrointestinal stromal tumors of the stomach in children and young adults: a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases with long-term follow-up and review of the literature. Am J Surg Pathol 29 (2005) 1373-1381
39. Prakash S., Sarran L., Socci N., DeMatteo R.P., Eisenstat J., Greco A.M., et al. Gastrointestinal stromal tumors in children and young adults: a clinicopathologic, molecular, and genomic study of 15 cases and review of the literature. J Pediatr Hematol Oncol 27 (2005) 179-187
40. Swallow C.J., and Catton C.N. Local management of adult soft tissue sarcomas. Semin Oncol 34 (2007) 256-269
41. Demetri G.D., von Mehren M., Blanke C.D., Van den Abbeele A.D., Eisenberg B., Roberts P.J., et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 347 (2002) 472-480
42. Holdsworth C.H., Badawi R.D., Manola J.B., Kijewski M.F., Israel D.A., and Demetri G.D. CT and PET: early prognostic indicators of response to imatinib mesylate in patients with gastrointestinal stromal tumor. AJR 189 (2007) W324-W330
43. Van den Abbeele A.D., and Badawi R.D. Use of positron emission tomography in oncology and its potential role to assess response to imatinib mesylate therapy in gastrointestinal stromal tumors (GISTs). Eur J Cancer 38 Suppl 5 (2002) S60-S65
44. Demetri G.D., van Oosterom A.T., Garrett C.R., Blackstein M.E., Shah M.H., Verweij J., et al. Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial. Lancet 368 (2006) 1329-1338
45. Scurr M., and Judson I. How to treat the Ewing's family of sarcomas in adult patients. Oncologist 11 (2006) 65-72
46. Temple H.T., Scully S.P., O'Keefe R.J., Katapurum S., and Mankin H.J. Clinical outcome of 38 patients with juxtacortical osteosarcoma. Clin Orthop Rel Res 373 (2000) 208-217
47. Lee J.A., Kim M.S., Kim D.H., Lim J.S., Park K.D., Song W.S., et al. Osteosarcoma developed in the period of maximal growth rate have inferior prognosis. J Pediatr Hematol Oncol 30 (2008) 419-424
48. Bielack S., Carrle D., and Jost L. Osteosarcoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 19 Suppl 2 (2008) ii94-ii96
49. Dantonello T.M., Int-Veen C., Leuschner I., Schuck A., Furtwaengler R., Claviez A., et al. Mesenchymal chondrosarcoma of soft tissues and bone in children, adolescents, and young adults: experiences of the CWS and COSS study groups. Cancer 112 (2008) 2424-2431
50. Zeltzer L.K. Cancer in adolescents and young adults psychosocial aspects. Long-term survivors. Cancer 71 Suppl (1993) 3463-3468
51. Zebrack B., Bleyer A., Albritton K., Medearis S., and Tang J. Assessing the health care needs of adolescent and young adult cancer patients and survivors. Cancer 107 (2006) 2915-2923
52. Meirow D., and Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update 7 (2001) 535-543
53. Ferrari A., Montello M., Budd T., and Bleyer A. The challenges of clinical trials for adolescents and young adults with cancer. Pediatr Blood Cancer 50 Suppl (2008) 1101-1104